Navigation Links
Baron and Budd Announces Second Transvaginal Mesh Lawsuit Settlement for Bard
Date:9/20/2013

Los Angeles, CA (PRWEB) September 20, 2013

Minutes before the trial proceedings for the second federal transvaginal mesh lawsuit for C.R. Bard’s Avaulta were scheduled to begin, news broke that Bard had settled with the plaintiff for an undisclosed amount. Considered a bellwether lawsuit that could help determine the future of subsequent transvaginal mesh claims, the settlement may portend that Bard and even other manufacturers of transvaginal mesh are more willing to settle cases instead of proceeding to public trial. (http://www.bloomberg.com/news/2013-08-21/bard-settles-vaginal-mesh-case-after-2-million-verdict.html)

Transvaginal mesh is a medical device that is manufactured and distributed by numerous pharmaceutical companies. Mesh device names and companies include C.R. Bard’s Avaulta, Johnson & Johnson subsidiary Ethicon’s Gynecare, Boston Scientific Scimmed’s Pinnacle pelvic mesh and American Medical System’s products including AMG BioArc, MiniArc, Monarc and Straight-In Mesh. While Bard has just settled its second federal transvaginal mesh lawsuit, many transvaginal mesh device manufacturers are facing similar transvaginal mesh lawsuits for injuries including bladder, bowel and even blood vessel perforation and the need for costly and sometimes even multiple revision surgeries. (http://www.fda.gov/medicaldevices/safety/alertsandnotices/publichealthnotifications/ucm061976.htm)

This settlement was decided just days after another jury found Bard liable in its first federal transvaginal mesh lawsuit, thereby awarding the plaintiff $2 million for her injuries. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, 10-md-02187. Queen’s case is Queen v. C.R. Bard Inc., 11-cv-00012, U.S. District Court, Southern District of West Virginia)

“These transvaginal mesh lawsuits are very complex,” said Laura Baughman of Baron and Budd. “Our goal is to get our clients the compensation they deserve for the severe injuries transvaginal mesh caused."

For more information about the transvaginal mesh lawsuit, please call the transvaginal mesh lawyers at Baron and Budd at 1.866.472.9108 as soon as you can. There is a limited window of opportunity to file transvaginal mesh lawsuits, and we do not want you or a loved one to miss your chance to seek compensation for your injuries. Visit our website for more information: http://baronandbudd.com/areas-of-practice/pharmaceuticals/transvaginal-mesh-litigation/

About Baron & Budd, P.C.

With a history of over 35 years “Protecting What’s Right” for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11136807.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Baron and Budd is Encouraged by the First Federal Transvaginal Mesh Lawsuit Verdict
2. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
3. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
4. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
5. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
6. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
7. 360Websitedesign Announces Website Maintenance Services
8. ELK Consulting announces their new editing service
9. Zion Health Announces Native Remedy; Ancient Clay Soaps for Sensitive Skin; New Addition to Whole Foods Market Body Care in Andover, MA
10. Heroes in Recovery Announces Second Annual Race in Roswell, Georgia
11. Fitness 19 Announces the Opening of the Newbury Park, CA Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special ... Train” is the creation of published author, Janet Morrison, who has been writing mostly ... "Fred, the Dog" series is her first attempt at writing for children. Janet, Fred, ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... PHILADELPHIA , Dec. 7, 2016  Lannett Company, Inc. (NYSE: ... at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference ... Barclay hotel in New York City . ... investors participating at the Guggenheim Securities 4 th Annual Boston ... Boston hotel. ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology: